Participated · Series A · Dec 2025

Headquartered in San Francisco and led by CEO Jay Dawani, Lemurian Labs has built a platform that combines compiler technology with runtime orchestration to let developers write AI code once and deploy it on any hardware. Its hardware-agnostic approach promises faster deployment cycles, greater flexibility and lower infrastructure costs at scale. The company is positioning the platform for organizations seeking sustainable compute and open AI innovation. Fresh capital will be directed toward expanding the engineering team, accelerating product development and deepening partnerships across the AI ecosystem. Although specific revenue or user figures were not disclosed, the company previously completed a seed round in 2022. Lemurian Labs believes its technology can reduce the friction of moving AI workloads between edge devices, cloud instances and on-prem servers, potentially widening its addressable market.

Led · Seed · Nov 2025

Extellis designs and plans to operate satellites built to capture high-frequency synthetic aperture radar (SAR) imagery, with the company claiming each satellite can capture thousands of images per day using patented antenna technology developed at Duke University from DARPA-sponsored research. The platform is intended to provide consistent monitoring that works at night and through clouds, smoke and other conditions that limit optical imagery. Extellis targets infrastructure operators and industrial companies—such as pipeline, transportation and energy facility operators—that need frequent, wide-area visibility of distributed assets. The company is preparing a pathfinder mission to test technology and operating capabilities ahead of broader commercial service and is building the infrastructure required to serve industrial customers. Extellis recently expanded its seed financing with investment from Shell Ventures to support the pathfinder mission, team expansion and progress toward commercial operations. The company positions its offering as an alternative to helicopters, ground inspections and optical satellite imagery for more dependable, high-frequency monitoring.

Led · Series A · Apr 2023

Emrgy designs and deploys proprietary modular turbine technology that integrates into existing waterways and surface water conveyance infrastructure to deliver continuous, low-cost renewable power with minimal disruptive construction. The company focuses on decarbonizing the water-energy nexus by supplying power to agricultural, municipal, and utility offtakers. With an $18.4M Series A, Emrgy plans to deploy distributed hydropower projects across the Western US, Europe, and Australasia and to open a turbine assembly facility in Aurora, Colorado. The inaugural manufacturing facility is expected to have a capacity of 5MW per month and to employ up to 30 engineers and operations specialists in 2023. Emrgy's technology has been deployed with customers including Denver Water, Davis and Weber Counties Canal Company, and Oakdale Irrigation District, and the company has projects in New Zealand and a pilot system in South Africa. The company will expand its development, operations, and engineering teams as part of the growth plan.

Participated · Series C · May 2022

TARGAN is a technology provider focused on solving pressing issues in worldwide food production. Its flagship product, WingScan, is gaining rapid traction across the United States, Europe, and South America, with new markets coming on board every month. The company states it is entering an extraordinary growth phase and intends to scale its operations significantly. Management plans to channel new capital into infrastructure development that will underpin the next wave of product launches. This strategy is aimed at accelerating market expansion and reinforcing TARGAN’s leadership in food-production technology.

Led · Series B · Nov 2021

Medicom Technologies is a health-focused technology company that originated from research and connections at N.C. State. The firm operates in the broader health-tech sector, though specific product details were not disclosed in the available material. It recently secured $4 million in fresh capital, signaling early external validation of its offering and growth prospects. Management has indicated plans to seek additional funding beyond this initial raise, underscoring an ambition to scale operations further. No revenue figures, user counts, or other operating metrics were provided in the article, so the company’s current commercial traction remains undisclosed. Nevertheless, the new financing strengthens its balance sheet and positions Medicom Technologies to advance product development and market expansion plans once additional capital is secured.